Global Clinical Trials, LLC is a Contract Research Organization with operations in Russia, former Soviet Republics and Eastern Europe. GCT is headquartered in Princeton, NJ, USA with full service offices in
New positions! We seek CRAs and Project Managers in Russia.
See career section for details.
Enrollment completion

One of the major hospitals participating in the program, St. Petersburg, Russia
Global Clinical Trials announces the completion of enrollment for two large women's health projects. During the month of May we have successfully completed enrollment of two studies in Mixed Bacterial Vaginosis / Vulvovaginal Candidiasis Infections. The first trial required 29 sites to enroll 393 patients and the second trial required 20 sites to enroll 209 patients. GCT will continue to monitor both projects through to their successful completion this summer.
May, 2009; Moscow, Russia
Industry meetings

Our booth section at EuroDIA, Berlin
The month of April concluded with GCT attending the 18th Annual Partnerships Meeting in Orlando, Florida. GCT shared a booth with our US partner, ResearchPoint Global, promoting our shared capabilities to provide global trial support. During the end of March we have attended and exhibited at the 21st Annual European DIA meeting in Berlin, Germany.
The meetings gave us the opportunity to promote our services to both current and potential clients and catch up on Industry trends and changes. Both meetings proved to be successful and well attended. Our next meeting will be at the end of May for the ASCO meeting in Orlando, Florida. If you would like to meet with us at any meeting please submit your request. We look forward to seeing both old and new clients at ASCO.
April, 2009; St. Petersburg, Russia
Oncology program completion
Global Clinical Trials, LLC successfully accomplished an International Multicentre Phase II trial studying the primary systemic therapy for women with operable breast cancer.
This was 3 year project, a part of a European Cooperative involving more than 12 other countries globally to measure the current success of treatment.
March, 2009; St. Petersburg, Russia
New project in Russia
We are happy to announce the approval of another submission to the Ministry of Health for an NCE. With this approval the trial, for surgical pain, will now move forward with applications for importation and exportation of clinical trial materials. It is expected that all sites will be initiated by March 15th and the first patient enrolled will follow shortly thereafter. This project will involve 80 patients at 4 sites over a 50 week duration. Congratulations and Good Luck to the clinical teams for a rapid enrollment and a successful project.
February, 2009; Moscow, Russia
Previous postings
- Oncology study in Ukraine
- FDA audit
- Global Clinical Trials makes management changes
- GCT expands Drug Storage and Central Pharmacy capabilities
- Investigator Meetings in September
- Enrollment completed ahead of schedule
Older postings are in the archive
privacy statement, website info




